Insomnia Clinical Trials 2024

Insomnia Clinical Trials 2024

Insomnia research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in insomnia clinical trials today.

Insomnia Clinical Trials

Here are the 6 most popular medical studies for insomnia

Popular filter options for insomnia trials

Chronic Insomnia Clinical Trials

View 17 Chronic Insomnia medical studies.

Major Depressive Disorder Clinical Trials

View 12 Major Depressive Disorder medical studies.

Insomnia Clinical Trials With No Placebo

View 96 insomnia medical studies that do not have a placebo group.

View More Insomnia Trials

See another 69 medical studies focused on insomnia.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to insomnia

What are the top hospitals conducting insomnia research?

When it comes to tackling the complex issue of insomnia, top hospitals across the United States are actively engaged in clinical trials to find innovative solutions. In Philadelphia, the University of Pennsylvania is leading the way with four ongoing insomnia trials. Known for its cutting-edge research and expertise, this institution aims to improve sleep quality and address the underlying causes of this prevalent condition. Meanwhile, on the West Coast in Palo Alto, California, the VA Palo Alto Health Care System is making strides with three active insomnia trials. Collaborating closely with veterans who often face sleep disturbances as a result of various factors, this hospital seeks to enhance their well-being through groundbreaking treatments.

In Charlottesville, Virginia, researchers at the University of Virginia are also dedicated to unraveling mysteries surrounding insomnia by conducting three active clinical trials. With an emphasis on understanding individual differences in sleep patterns and tailoring interventions accordingly, they strive towards personalized medicine in treating this common disorder.

Similarly committed to advancing our knowledge about effective approaches against insomnia is San Francisco's own San Francisco VA Medical Center. Their current focus lies within three ongoing clinical trials aimed at identifying novel therapies that can help individuals obtain restorative sleep.

Not far from there—located at Columbia—is another key player in these efforts: The University of Missouri—a hub where scientists conduct research while simultaneously running three promising active insomnia-related studies aiming for amelioration via tailor-made remedies catering differing subjective predicaments faced by each insomniac

These esteemed institutions represent beacons of hope for those affected by chronic sleeplessness. By delving into new avenues through rigorous scientific investigations and patient collaboration nationwide , they offer prospects for improved diagnosis methods as well as more efficient treatment options that may ultimately grant many a good night's rest

Which are the best cities for insomnia clinical trials?

When it comes to insomnia clinical trials, several cities stand out as leaders in research and development. Boston, Massachusetts leads the way with 9 active trials exploring treatments like Bioboosti, Sleep ALL Night, and suvorexant. Philadelphia, Pennsylvania closely follows with 8 ongoing studies focused on interventions such as Sleep Hygiene and Solriamfetol+ CBT-I. Tucson, Arizona and San Francisco, California both offer 7 active trials addressing various approaches like In-person CBTi and Apnea and Insomnia Relief (AIR). Lastly, Baltimore, Maryland conducts 6 active trials examining strategies including Cognitive-Behavioral Therapy for Insomnia (CBT-I) and Light therapy. These cities provide individuals struggling with insomnia access to cutting-edge clinical trials that may pave the way for effective treatment options in the future.

Which are the top treatments for insomnia being explored in clinical trials?

Insomnia research is actively investigating various treatments to alleviate this sleep disorder. Among the top contenders in clinical trials are:

  • Tasimelteon: Currently undergoing testing in two active trials for insomnia.
  • Suvorexant: Garnering attention with three ongoing clinical trials focused on treating insomnia.
  • Ramelteon: Being explored as a potential solution for insomnia, with one active trial dedicated to its evaluation. These promising treatments offer hope for individuals struggling with insomnia and may bring new possibilities for better sleep quality and overall well-being.
What are the most recent clinical trials for insomnia?

Recent clinical trials have brought forth promising developments in the field of insomnia treatment. One notable study explored a new therapeutic approach for insomnia, while another investigated the combination of solriamfetol and cognitive-behavioral therapy for insomnia (CBT-I). Additionally, researchers examined the effectiveness of pimavanserin when administered at a dose of 34mg orally before bedtime. Another trial focused on evaluating SHUTi OASIS, an intervention designed to address insomnia-related concerns. Lastly, suvorexant was studied as a potential treatment option for individuals suffering from insomnia. These innovative trials offer hope for improved management and relief from this sleep disorder.

What insomnia clinical trials were recently completed?

Several recent clinical trials have investigated potential treatments for insomnia, a common sleep disorder that affects many individuals. These trials aimed to address the challenges of insomnia and enhance our understanding of effective interventions. While specific trial details vary, notable completed studies include investigations into both pharmacological and non-pharmacological approaches. By focusing on this important area of research, scientists are working towards improving the quality of life for those affected by insomnia.